Anesthetic Management of Patient With Chronic Renal Failure Dr Sanjeev Aneja MD. DNB, FFARCS Sr Consultant in Anesthesia & Intensive Care www.anaesthesia.co.inwww.anaesthesia.co.in.

Slides:



Advertisements
Similar presentations
CHRONIC KIDNEY DISEASE Chronic kidney disease is the slow loss of kidney function over time. The main function of the kidneys is to remove wastes and excess.
Advertisements

Management of Stage 3 Chronic Kidney Disease (CKD) in General Practice
QUOTATIONS Brethren, let’s tee off with these germane quotable quotes:- The death of every man diminishes me, for I’m involved in Mankind. The death of.
Diabetes, Anemia and Chronic Kidney Disease Josephine Carlos-Raboca,M.D., F.P.S.E.M., Endocrinology, Diabetes and Metabolism Makati Medical Center.
SOCIETY OF RENAL NUTRITION AND METABOLISM (SRNM)
Introduction to Nephrology Sandeep K. Shori, D.O. Dialysis Associates Fort Worth, TX.
Dietary Approach To C Kidney Disease
Decreased Nuclear Receptor Activity Mediates Downregulation of Drug Metabolizing Enzymes in Chronic Kidney Disease Through Epigenetic Modulation October.
Spinal injury and anaesthesia Dr Ashish Moderator :Dr R.Tope
Chronic Kidney Disease and Dialysis Patient Care – What the Generalist Should Know Stephen R. Ash, MD, FACP Clarian Arnett Health Director of Dialysis,
Mayrene Hernandez, DO Advanced ProMed Inc. Billing and Management Solutions Board Certified in Family Medicine Clinical Assistant Professor for NSU.
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
CHRONIC KIDNEY DISEASE The Philippine Situation
Chronic Kidney Disease/Dialysis Belinda Jim, MD January 15, 2009.
Drug therapy in renal failure Kari Laine, MD, PhD University of Turku & medbase Ltd.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
ACUTE RENAL FAILURE INTERN EMERGENCY LECTURE SERIES 2005.
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Dialysis and Kidney Transplant (Relates to.
Anemia Guidelines and The Use of Erythropoietin in Turkey
The kidney,chronic kidney disease and WAGR kidney disease
Cardiovascular and All-Cause Mortality Outcomes Among Hypertensive Patients With Moderate Renal Dysfunction in the ASCOT- LLA, and its.
CKD In Primary Care Dr Mohammed Javid.
Estimation of Serum Urea Haematology lab Miss. Tahani Al Shehri.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Section 1: CKD Epidemiology. The Problem Chronic Kidney Disease is an epidemic worldwide –Growth 6-8% per annum of dialysis patients Accumulating data.
Renal Clearance The renal clearance of a substance is the volume of plasma that is completely cleared of the substance by the kidneys per unit time.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
CGS BILLING SERVICE
Acute Renal Failure Hai Ho, M.D..
Dose Adjustment in Renal and Hepatic Disease
Ricki Otten MT(ASCP)SC
... Assessing renal function in the elderly The development of a new Iohexol based method to measure the true Glomerular Filtration Rate Gijs Van Pottelbergh,
Ask Yourself! Can it be filtered? Is it reabsorbed? Is it secreted? What factors regulate the amount filtered, reabsorbed, and secreted? –Size –Permeability.
CKD update Dr Saqib Mahmud MRCP(UK),MRCGP. Chronic kidney disease Defined by a reduced eGFR, proteinuria, haematuria and/ or structural abnormalities.
Section 5: Configuration of healthcare to manage CKD.
BIOS 162 Graduate Review: Final! December 11, 2011.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Renal Disease Normal Anatomy andPhysiology. Renal: Normal Anatomy 1. Renal artery and vein: 25% of blood volume passes through the kidney / minute 2.
CKD Dr;BASHARDOOST. CKD –SOME DEFINITIONS IRREVERSIBLE LOSS OF GFR CKD results when a disease process damages the structural or functional integrity of.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Lecture – 3 – Major renal syndromes Dr.Hazem.K.Al-Khafaji MBCHB.D.M.FICMS.
Clinical significance of BUN & creatinine BM 黃雅筠.
What is PD2010_023 Policy Directive from NSW DOH, 15th April 2010
Dr. Aya M. Serry Renal Failure Renal failure is defined as a significant loss of renal function in both kidneys to the point where less than 10.
Anatomy Chronic Kidney DiseaseLECTURE-9-  Hazem.Kadhum Al-khafaji  MD.FICMS  Department of medicine  Al-Qadissiah university.
Chronic renal failure and common accompanying diseases Hradec Králové, November 2007 © by Adrian Franke.
Non-Protein Nitrogen (NPN) Compounds (Urea, Creatinine & Uric Acid)
Federal Register, May 4, New ICD-9-CM codes for CKD, showing revisions Revise585Chronic renal failure Chronic kidney disease (CKD) AddUse additional.
Non-Protein Nitrogen(NPN) Compounds
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of a Treatment Strategy Consisting of Pravastatin,
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
CLINICAL APPLICATION OF UREA MEASUREMENTS METABOLIC ASPECTS OF KIDNEY METABOLISM.
CKD Update Naveed Ghaffar CKD Lead NMCCG. Outline Introduction- CCG Work Physiology: The Kidney in health CKD : The kidney in disease NICE Update: July.
Revision for Clinical Biochemistry Lab
Renal Disorders NUR 171 Professor Losicki R.N. MSN.
CARLY LAURAINE KEENE STATE DIETETIC INTERN SAMARITAN MEDICAL CENTER Final Case Study Presentation.
Section 1: CKD Epidemiology
Correlation between SCr and GFR
Lab (5): Renal Function test (RFT) (Part 2)
Revision for Clinical Biochemistry Lab
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised,
Get Help-Gmail help number
End point Patients >75 y with renal insufficiency
Diuretics, Kidney Diseases Urine R&M
Meeting the challenges of the new K/DOQI guidelines
Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%
Presentation transcript:

Anesthetic Management of Patient With Chronic Renal Failure Dr Sanjeev Aneja MD. DNB, FFARCS Sr Consultant in Anesthesia & Intensive Care

Important Terms & Definitions  Renal Failure Chronic Renal Failure  GFR  Creatinine Clearance  Azotemia & Uremia  BUN/ Creatinine  Auto regulation of Renal blood Flow

Chronic Kidney Disease  Presence for at least three months of either of the following Structural or functional abnormality of kidney with or without fall in GFR GFR <60ml/ml/1.73sq mt (NKF 2003)

Stages of Chronic Kidney Disease (NKF,2003) StageDescriptionGFR 1Kidney Damage with normal GFR >/=90 2Kidney Damage with mild fall in GFR Moderate fall in GFR Severe fall in GFR Kidney Failure<15

GFR  Best overall measure of function  Normal level of GFR varies with age, sex & physiological state  25% of individuals above 70 yr of age have GFR <60 ml  GFR is estimated from urinary clearance of a filtration marker

GFR contd.  Estimation of GFR using exogenous filtration marker  Estimation of GFR using endogenous filtration markers urea creatinine Cystatin C

GFR contd  Estimating equations for GFR using serum creatinine  Cockcroft-Gault Equation Ccr= (140-Age) x weight( 0.85 if female)/(72xPcr) MDRD study equation

Chronic Kidney disease & Anesthetist  Patients on replacement support pts. With GFR<15 ml pts. With GFR ml Patents with GFR ml

Discussion  History Duration of disease Cause of disease Manifestation of systemic disease Complications of CRF

History  Type of dialysis  Frequency of dialysis  Tolerance of dialysis  Dry weight of the patient

Physical Examination Mark & Record the site of venous access for Dialysis

Cardiovascular Disease in CKD  CVD is the main cause of death in patients with CKD  Persons with CKD are predisposed to three types of CVD—atherosclerosis, arteriosclerosis, and cardiomyopathy

CVD in CKD  Hypertension  Uremia  Anemia  Coronary & valvular calcification  Dyslipidemia  Increased markers of inflammation

CVD in CKD No guidelines for cardiovascular evaluation in ESRD patients Pt. <50yr no diabetes & symptom of CAD Pt..50yr with diabetes without symptom of CAD Pt. With symptom of CAD or CHF

Assessment of Other Systems  Respiratory  Hematology   Fluid & Electrolyte  Gastro intestinal

Pre Operative Preparation  Treat anemia  Dialysis When to Dialyse How much fluid to be removed Effects of Dialysis

Anesthesia planning  GA Vs Regional  Premedications  Intraoperative Management  Post operative pain & fluid management

Anesthesia for Renal Transplantation 1936 (VORONOY)1 st Cadaver Human Renal Allograft 1954 (MERRILL)1 st Living related donor graft between twins. 5 Years Survival After Transplants: 70% After Dialysis:30% (8 out of 23,546 Pts.) (Anaestesiology clinics of North America, 22, 2004)

Surgical Field: Renal Transplant Extra Peritoneal Donor Renal Artery To external / common iliac Artery Donor Renal Vein To external / common iliac vein Donor Ureter To Bladder (Ureterocystostomy)

Pre-operative Preparation Pre-Op visitReassurance ICU Stay/Central Line/Pain Relief/PCA-Epidural. Hep. B,C/ HIV Status. A-V Fistula Fluid/Electrolyte Status Plan of Immunosuppression Therapy – Cotisone / Cychosparin / Azathioprine

Choice of Anaesthetic Technique General Anaesthesia (GA) Regional Anaestehsia (RA) – Spinal/Epidural/CSE Combination of GA + RA ? Epidural haematoma ? Use of RA in Autonomic neuropathy ?Use of Vasopressors (avoided)

Conduct of Anaesthesia Induction: Rapid Sequence induction Propfol / Thiopentone / Ketamin Fentanyl (5mcg/kg) / Esmolol Atracurium / O 2 + N 2 O + isoflurane ? Sevoflurane (Compound A controversy)

Equipment / Monitoring Sterile disposable anaesth. circuits / ETT / Laryngoscope Use of gloves / Gowns / IV Lines (avoid forearm) NIBP / ECG / SPO2 / ETCO2 / PN Stimulator / agent / Temperature / CVP (IJV) / Urine Output Electrolytes / ABG / haemotocrit ? IBP / ?PAWP

Fluid & Diuretic Therapy (Intra – op.)  Adequacy of Perfusion at vascular clamp release.  Intra-op volume expansion - ↑ RBF & improved immediate graft function / graft survival / lower pts mortality.  Guided by CVP (10-15cm H 2 O) Small vol. colloid / N-saline (Avoid RL)  Cadaver Kidney – needs ↑ BP & ↑ plasma vol. to initiate diuresis than normal kidney.  Frusemide / Mannitol / Dopamine infusion.

Immunosuppression Methyl Prednisolon – (500 mg. Solumedrol) IV Slowly (30-60 mins) before transplant. Cardiac Arrest Arrhythmias Circulatory Collapse Azathioprim Cyclosporin

Post operative period Recovery ICU Stay – Protocols – Fluid / Urine output. Pain Relief – PCA / Epidural Haemodialysis CXR

Dual Kidney Transplant Two kidneys from aged donor are placed in to one recipient. Long duration of surgery / Otherwise no difference in management.

Thank you

Clinical settings when BUN and creatinine levels may not reflect alteration in renal function High urea with normal renal function: Hypercatabolism, high protein load, GI bleed, hematoma breakdown Normal urea with decreased renal function: Decreased urea synthesis in hepatic failure or malnutrition High creatinine with normal renal function: Excess creatinine release due to seizures, muscle injury, inflammation, or ischemia Normal creatinine with decreased renal function: Decreased creatinine synthesis from muscle due to malnutrition or atrophic muscular disorders